Assessment/registration | Baseline | 3-month follow-up | 12-month follow-up | Long-term follow-up |
---|---|---|---|---|
Demographics | x | |||
Medical history | x | |||
Medication use | x | |||
Admission NIHSS score | x | |||
Symptom onset and admission time | x | |||
Acute treatment | x | |||
Standard blood chemistry at admission | x | |||
Pre-stroke mRS | x | |||
IQCODE | x | |||
Height, weight and BP | x | x | x | |
Smoking and alcohol use | x | |||
MoCA | x | x | x | |
PASE | x | x | x | |
WHO-5 | x | x | x | |
MDI | x | x | x | |
Educational level | x | |||
New vascular events | x | x | x | |
Functional outcome: mRS | x | x | ||
Stroke classification: TOAST and OSCP | x | |||
RBANS | x | x | ||
Blood sample for EVs* | x | x | ||
Blood sample for APOE genotyping | x | |||
MRI** | x | x | ||
Dementia | x |